A new study has discovered that patients with high blood pressure and abnormalities in the  periventricular white matter in the brain showed signs of cognitive impairment despite taking medication to lower their blood pressure.

High blood pressure has been linked to an increased risk for dementia, but what’s unclear is what kinds of subtle negative changes take place in the brain that may affect cognitive function, according to researchers. Finding new ways to detect minor types of cognitive impairment may help determine who is at risk for early-stage dementia, they noted.

In the study, researchers looked at 345 men and women with a median age of 65 who had high blood pressure.

Patients underwent brain imaging scans, were tested in cognitive function areas including execution, memory, and attention, and were followed for about four years.

Average blood pressure during follow-up was 144.5/76.5 mm Hg. The American Heart Association/American College of Cardiology 2017 hypertension guidelines revised the definition of hypertension, classifying it as a blood pressure reading of 130/80 mm Hg instead of 140/90.

To understand what was going on in the brain, researchers looked at the white matter. White matter is important because it connects different regions of the brain, serving as a kind of infrastructure, the researchers explain.

Specifically, researchers looked at periventricular white matter, located in the central part of the brain, which acts as a bridge between distant brain regions and serves an important role in cognitive function. Lesions or abnormalities found in periventricular white matter could signal cognitive impairment, they note.

During the study, 9 percent of the group developed mild cognitive impairment. There was also a connection between periventricular white matter changes and the risk of mild cognitive impairment. Researchers found that patients with a progression of periventricular white matter abnormalities showed a six-fold increased risk of mild cognitive decline.

The researchers observed that the progression of periventricular white matter abnormalities aligned with cognitive decline in global and executive function. Small vessel bleeding in the brain was found to be related to a decline in attention, they add.

Although the development of brain lesions may be considered “silent” conditions in which patients do not feel or are unaware of symptoms, if left untreated, the risks of more severe forms of cognitive decline may increase, the researchers said.

They added that more study is needed to better understand how periventricular white matter changes triggers cognitive decline.

“The brain is an organ exposed to a high volume of blood flow and it is very vulnerable to sustained high blood pressure levels, and this might be happening silently or with mild symptoms, but that doesn’t mean there aren’t consequences,” said lead author Joan Jiménez Balado, Ph.D. ,M.Sc. in Neuroscience at the Institut de Recerca Hospital Vall d’Hebron in Barcelona, Spain.

“High blood pressure and its consequences are really ‘covert’ diseases that tend to progress if it is not well managed.”

The study was published in the American Heart Association’s journal Hypertension.

Source: The American Heart Association